Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
May 15, 2024 07:01 ET
|
Olema Oncology
Across 50 treated patients, palazestrant (OP-1250) in combination with ribociclib was well tolerated with no new safety signals or increased toxicity and no clinically meaningful impact on drug...
BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024
May 15, 2024 07:00 ET
|
BiomX
GAITHERSBURG, Maryland and NESS ZIONA, Israel, May 15, 2024 (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company advancing novel natural and...
BurgerFi Reports First Quarter 2024 Results
May 15, 2024 07:00 ET
|
BurgerFi International
FORT LAUDERDALE, Fla., May 15, 2024 (GLOBE NEWSWIRE) -- BurgerFi International, Inc. (Nasdaq: BFI, BFIIW) (“BurgerFi” or the “Company”), owner of BurgerFi, one of the nation’s leading fast-casual...
Edible Garden Reports Significant 27.6% Year-Over-Year Revenue Growth for First Quarter of 2024
May 15, 2024 07:00 ET
|
Edible Garden AG Incorporated
195.8% Gross Profit Increase in Q1 2024 with Gross Margin Increasing by 171 Basis Points 95% of Edible Garden Fresh Product Line Being Produced at Company-Owned Facilities - Strategic Pivot Away from...
Renalytix Reports Financial Results for Third Quarter of Fiscal Year 2024
May 15, 2024 07:00 ET
|
Renalytix plc
LONDON and NEW YORK, May 15, 2024 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical...
Bitfarms Reports First Quarter 2024 Results
May 15, 2024 07:00 ET
|
Bitfarms Ltd.
- Revenue of $50 million, up 9% Q/Q and 67% Y/Y -- Gross mining margin of 59%, up from 52% in Q4 2023 & 41% in Q1 2023 -- Secured additional 24,000 miners in March, increasing total delivery to...
Global Patient Monitoring Devices Market Size To Exceed USD 103.82 Billion By 2033 | CAGR 7.97%
May 15, 2024 07:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States , May 15, 2024 (GLOBE NEWSWIRE) -- The Global Patient Monitoring Devices Market Size is to Grow from USD 48.23 Billion in 2023 to USD 103.82 Billion by 2033, at a Compound...
TFF Pharmaceuticals Provides Update on Tacrolimus Inhalation Powder (TFF TAC) Phase 2 Trial for the Prevention of Lung Transplant Rejection
May 15, 2024 07:00 ET
|
TFF Pharmaceuticals, Inc.
Patient Enrollment Has Accelerated with Now 10 Patients Enrolled in Phase 2 Trial 6 out of 6 Patients Who Completed the 12-Week Treatment Have Chosen to Remain on TFF TAC by Proceeding to the...
Sportradar Reports First Quarter 2024 Financial and Operating Results
May 15, 2024 07:00 ET
|
Sportradar AG
Achieved Record Revenue of €266 Million, Up 28% and Grew Adjusted EBITDA 29% Raising 2024 Outlook for Revenue and Adjusted EBITDA Commencing Purchases Under Previously Announced Share Repurchase...
Krystal Biotech to Present at the American Thoracic Society 2024 International Conference
May 15, 2024 07:00 ET
|
Krystal Biotech, Inc.
PITTSBURGH, May 15, 2024 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, announced today that the Company will be presenting new...